Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Walgreens Stock Rallies on J.P. Morgan’s Upgraded Outlook

Published 23/10/2023, 12:58
© Reuters.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) Inc. rallied today, following a bullish outlook by J.P. Morgan. Analyst Lisa Gill upgraded the stock to overweight and raised her price target to $30, which represents a 41% upside from last Friday's close of $21.26. This optimistic outlook is largely driven by the potential of incoming CEO Tim Wentworth to tackle ongoing challenges affecting the company's stock.

InvestingPro data reveals that Walgreens Boots Alliance Inc. has a market cap of 18.37B USD and has been experiencing revenue growth of 4.81%. Despite a challenging year for the company, its revenue for the last twelve months (LTM2023.Q4) stands at 139.08B USD.

The stock has had a challenging year, marked by missed earnings, high costs, and sluggish growth in its healthcare business, which led it to hit a 25-year low. Gill expects improvement under the leadership of Wentworth, who was formerly the CEO of Cigna (NYSE:CI) Group’s Evernorth.

InvestingPro Tips suggests that the company, a prominent player in the Consumer Staples Distribution and retail industry, has been maintaining its dividend payments for 53 consecutive years, which is likely to be a significant factor for investors. The company's dividend yield as of Y2023.D296 is 9.03%.

Today's rally saw the stock outpace the DJIA and SPX in premarket trading post-announcement. This comes after a year-to-date plunge of 43.1% and a three-month tumble of 30.2%, making it the worst-performing Dow component. According to InvestingPro's real-time metrics, the company's stock has fallen by 40.41% year-to-date, and by 28.95% over the last three months.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Wentworth is set to succeed Rosalind Brewer, who resigned on September 1st. Despite the recent rally, only four out of 16 FactSet analysts covering Walgreens maintain a bullish perspective on the stock. However, InvestingPro Tips indicates that net income is expected to grow this year, and analysts predict that the company will be profitable. For more insights like these, consider checking out the additional tips available on InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.